CLMT
NEUTRALMacroCalumet, Inc
This is the 2026-09-11 snapshot — the signals and analysis for CLMT as of this single trading day.
View full CLMT research hub →Analysis
Calumet's breakout to 52-week highs represents High-Conviction Price Discovery fueled by a massive structural catalyst: the EPA's recent small refinery exemption that wiped out a $170 million RIN liability. Despite a recent Q2 earnings miss, the stock is exhibiting profound relative strength (+18.7% vs SPY) and triggering PERFECT_STACK and MARKET_LEADER signals as institutional buyers aggressively accumulate shares following its C-Corp conversion. Supported by a RISK_ON macro regime and surging refining margins tied to oil crossing $100/barrel, the market is actively repricing CLMT's dramatically cleaner balance sheet. This divergence—ignoring past fundamental weakness to price in future regulatory relief—perfectly mirrors the broader market's willingness to look past hawkish macroeconomic data.
Fired Signals
Key Takeaways
- Actionable Thesis: The EPA's recent exemption removes 71 million RINs, structurally derisking CLMT's balance sheet and sparking multiple analyst upgrades (e.g., HC Wainwright to $75).
- Institutional Flow: Heavy accumulation from major funds (BlackRock, UBS) is driving technical momentum, further amplified by the company's recent C-Corp conversion and Russell index inclusion.
- Key Risk: The bullish thesis could be derailed by adverse rulings on the remaining 129 million RIN liabilities tied to 2022-2024 exemptions or a sudden collapse in crack spreads.